AzTrials
AzTrials

CardiologyNCT07514299

Investigation of the Effects of Pre-Angiography Music Interview and Aromatherapy Application on Pain, Anxiety, Fear, and Comfort Levels in Cardiology Patients

A study testing Lavender essential oil inhalation, Music intervention and routine care in people with Cardiology and Angiography, run by Istanbul Aydın University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study was conducted to examine the effects of non-pharmacological interventions applied before coronary angiography in cardiology patients. Specifically, the study focused on the use of music listening and lavender oil inhalation and their potential impact on patients' psychological and physical states prior to… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Cardiology, Angiography
What is being tested?
Lavender essential oil inhalation, Music intervention and routine care
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
139 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Nov 2024to 30 Jan 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • No sedation before or during angiography
  • No diagnosed psychiatric disorder
  • Normal sense of smell
  • No allergy to essential oils used
  • Voluntary participation
  • Scheduled for angiography within 24 hours
Show all 12Show fewer
  • Independent in activities of daily living
  • Literate (able to read and write)
  • No hearing impairment
  • Able to communicate effectively
  • No respiratory disease (e.g., asthma, COPD)
  • Not using non-pharmacological methods (e.g., yoga, reiki

Who cannot join

  • Communication problems
  • Psychiatric disorder diagnosis
  • Allergy to essential oils
  • Impaired sense of smell
  • Dislike or discomfort with lavender scent
  • Refusal to participate
Show all 9Show fewer
  • Respiratory disease (e.g., asthma, COPD)
  • Peripheral vascular disease
  • Neurological disorder

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Istanbul Aydin University

    Istanbul, Istanbul, 34295

Other trials in Turkey (Türkiye)

About this study

This study was conducted to examine the effects of non-pharmacological interventions applied before coronary angiography in cardiology patients. Specifically, the study focused on the use of music listening and lavender oil inhalation and their potential impact on patients' psychological and physical states prior to the procedure. The research was designed as a randomized controlled experimental study, in which participants were assigned to intervention and control groups for comparison.

Within the scope of the study, pain, anxiety, fear, and comfort levels were evaluated using standardized measurement tools, and data were collected through pre- and post-intervention assessments. The study emphasizes the importance of integrating complementary methods into clinical practice within a holistic nursing care approach.

Overall, the study aims to provide scientific evidence regarding the applicability of music therapy and aromatherapy as supportive, non-pharmacological interventions in the pre-angiography care of cardiology patients.

Being tested
Lavender essential oil inhalation, Music intervention, routine care
Keywords
Cardiology, Music, Aromatherapy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Lavender essential oil inhalationOther

    Patients in the aromatherapy group received lavender essential oil inhalation therapy, in which three drops of lavender oil were applied to a sterile sponge and held approximately 5 cm from the patient's nose for 5 minutes.

  • Music interventionOther

    Patients in the music intervention group listened to relaxing classical music through headphones for 10 minutes in the waiting area before the angiography procedure.

  • routine careOther

    Routine care before angiography includes patient assessment, ensuring fasting, establishing intravenous access, adjusting medication, and preparing the patient physically and psychologically for the procedure.

Study groups in NCT07514299
Study groupRoleWhat they receive
Experimental (Lavender) GroupExperimentalPatients in the aromatherapy group received lavender essential oil inhalation therapy, in which three drops of lavender oil were applied to a sterile sponge and held approximately 5 cm from the patient's nose for 5 minutes. This distance was maintained to ensure standardization of the intervention.
Receives: Other: Lavender essential oil inhalation
Experiment (Music) GroupExperimentalPatients in the music intervention group listened to relaxing classical music through headphones for 10 minutes in the waiting area before the angiography procedure.
Receives: Other: Music intervention
Control GroupOtherParticipants in the control group received routine care without any additional intervention.
Receives: Other: routine care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Patient Information Form

    The Patient Information Form was developed by the researchers based on an extensive review of the literature. The form included questions designed to collect information about the socio-demographic and clinical characteristics of the participants. The variables included in the form were age, gender, education level, marital status, place of residence, income level, smoking status, presence of chronic disease, previous angiography experience, and other relevant health-related information.

    Measured: First day

  2. General Comfort Scale

    The scale is designed based on a taxonomic structure that includes three levels and four dimensions forming the theoretical components of comfort, and is used to determine needs and to evaluate the extent to which comfort-providing nursing interventions lead to an increase in expected comfort. The scale is a four-point Likert type and contains a total of 48 items. The response patterns of the scale, which consists of positive and negative items, are given in a mixed order. Accordingly, a high score (4) in positive items indicates high comfort, and a low score (1) indicates low comfort. In the evaluation of the scale, the obtained negative scores are reverse-coded and added to the positive items. The highest total score that can be obtained from the scale is 192, and the lowest total score is 48.

    Measured: First day

  3. General Comfort Scale

    The scale is designed based on a taxonomic structure that includes three levels and four dimensions forming the theoretical components of comfort, and is used to determine needs and to evaluate the extent to which comfort-providing nursing interventions lead to an increase in expected comfort. The scale is a four-point Likert type and contains a total of 48 items. The response patterns of the scale, which consists of positive and negative items, are given in a mixed order. Accordingly, a high score (4) in positive items indicates high comfort, and a low score (1) indicates low comfort. In the evaluation of the scale, the obtained negative scores are reverse-coded and added to the positive items. The highest total score that can be obtained from the scale is 192, and the lowest total score is 48.

    Measured: Second day

  4. Visual Analog Scale for Pain

    The VAS, developed by Price et al. (1983), is commonly used in research to assess the intensity of pain as experienced by patients. It is a reliable and valid instrument. The scale consists of a 10-cm line, which can be either horizontal or vertical, with one end marked as "No Pain" (0) and the other as "Worst Pain" (10). Patients are given clear instructions on how to use the VAS and are asked to mark the point on the line that best represents their level of pain. The distance from the "No Pain" end to the patient's mark is then measured in centimeters and recorded. The scale ranges from 0 to 10, where 0 indicates no pain and 10 represents the worst possible pain.

    Measured: First day

  5. Visual Analog Scale for Pain

    The VAS, developed by Price et al. (1983), is commonly used in research to assess the intensity of pain as experienced by patients. It is a reliable and valid instrument. The scale consists of a 10-cm line, which can be either horizontal or vertical, with one end marked as "No Pain" (0) and the other as "Worst Pain" (10). Patients are given clear instructions on how to use the VAS and are asked to mark the point on the line that best represents their level of pain. The distance from the "No Pain" end to the patient's mark is then measured in centimeters and recorded. The scale ranges from 0 to 10, where 0 indicates no pain and 10 represents the worst possible pain.

    Measured: Second day

  6. Visual Analog Scale for Fear

    Fear levels were measured using a similar Visual Analog Scale, ranging from 0 to 10, where 0 indicates "no fear" and 10 represents "extreme fear". Participants were asked to mark the point on the scale that best represented their fear level before the angiography procedure.

    Measured: First day

  7. Visual Analog Scale for Fear

    Fear levels were measured using a similar Visual Analog Scale, ranging from 0 to 10, where 0 indicates "no fear" and 10 represents "extreme fear". Participants were asked to mark the point on the scale that best represented their fear level before the angiography procedure.

    Measured: Second day

  8. Visual Analog Scale for Anxiety

    Participants' anxiety levels were also measured using a Visual Analog Scale ranging from 0 (no anxiety) to 10 (extreme anxiety). The scale allows patients to subjectively evaluate the severity of their anxiety at the time of assessment.

    Measured: First day

  9. Visual Analog Scale for Anxiety

    Participants' anxiety levels were also measured using a Visual Analog Scale ranging from 0 (no anxiety) to 10 (extreme anxiety). The scale allows patients to subjectively evaluate the severity of their anxiety at the time of assessment.

    Measured: Second day

  10. State-Trait Anxiety Inventory

    The State Anxiety Scale is a highly sensitive tool for assessing rapidly changing emotional reactions. It provides information about an individual's operational anxiety. It is a four-point scale ranging from "none" to "completely." The Trait Anxiety Scale, on the other hand, requires the individual to describe how they generally feel. The State Anxiety Scale includes both direct and inverted statements. Direct statements indicate negative emotions, while inverted statements indicate positive emotions. The final value obtained is the individual's anxiety score. In interpreting the scores, the total score obtained from both inventories ranges from 20 to 80. A high score indicates a high level of anxiety, while a low score indicates a low level of anxiety.

    Measured: First day

  11. State-Trait Anxiety Inventory

    The State Anxiety Scale is a highly sensitive tool for assessing rapidly changing emotional reactions. It provides information about an individual's operational anxiety. It is a four-point scale ranging from "none" to "completely." The Trait Anxiety Scale, on the other hand, requires the individual to describe how they generally feel. The State Anxiety Scale includes both direct and inverted statements. Direct statements indicate negative emotions, while inverted statements indicate positive emotions. The final value obtained is the individual's anxiety score. In interpreting the scores, the total score obtained from both inventories ranges from 20 to 80. A high score indicates a high level of anxiety, while a low score indicates a low level of anxiety.

    Measured: Second day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Apr 2026
  2. Study start1 Nov 2024
  3. Primary completion30 Dec 2025
  4. Study completion30 Jan 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
This study employed a randomized controlled experimental design with a pretest-posttest control group model. Participants were randomly assigned to intervention groups (music listening and lavender aromatherapy) or a control group receiving routine care. The model was structured to evaluate the causal effects of non-pharmacological interventions on patient outcomes by comparing measurements obtained before and after the interventions across groups.
Masking
Single blind
Who is masked
Participant
Enrolment
139 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07514299
Sponsor's protocol ID
MUSIC AND AROMATHERAPY
Status last verified
Mar 2026
First submitted
25 Mar 2026
Last updated
7 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Amin, A., Amraei, M., Shahijan, M., Nadri, S., & Moradifar, N. (2021). The effects of aromatherapy on patients undergoing coronary angiography: A systematic review of clinical trials. Journal of Herbmed Pharmacology, 11(1), 1-9. https://doi.org/10.34172/jhp.2022.01 Auliya, K., Suryani, R., & Yudha, M. (2024). Implementasi Aromaterapi Mawar Untuk Mengurangi Kecemasan Pre Operasi Pada Pasien Sectio Caesarea Dengan Anestesi Spinal. Kolaborasi Jurnal Pengabdian Masyarakat, 4(5), 364-372. https://doi.org/10.56359/kolaborasi.v4i5.408 Borges, A. (2025). Lavender, Peppermint, Neroli, and Eucalyptus in the Modulation of Pain and Anxiety: A Critical Review of Aromatherapeutic Approaches. Brazilian Journal of Health Aromatherapy and Essential Oil, 2(1), bjhae24. https://doi.org/10.62435/2965-7253.bjhae.2025.bjhae24 Devi, S., Agustini, T., & Taqiyah, Y. (2023). Aromaterapi Lavender dalam Menurunkan Tingkat Kecemasan Pasien Pre Operasi Sectio Caesarea. Window of Nursing Journal, 153-159. https://doi.org/10.33096/won.v4i2.521 Dwitanta, S. (2024). AROMA THERAPY INTERVENTION TO IMPROVING SLEEP QUALITY IN PATIENTS WITH CARDIOVASCULAR PROBLEMS. Jurnal Keperawatan Malang, 9(2), 130-139. https://doi.org/10.36916/jkm.v9i2.271 Eslami, J., Ebrahimi, A., Hosseinkhani, A., Khazaei, Z., & Darvishi, I. (2018). The effect of aromatherapy using Lavender (Lavandula angustifolia Miller) and Citrus aurantium L. extracts to treat anxiety of patients undergoing laparoscopic cholecystectomy: A randomized clinical trial in Iran. Biomedical Research and Therapy, 5(3), 2096-2110. https://doi.org/10.15419/bmrat.v5i3.423 Eğilmez, O., Güven, M., Yılmaz, A., Güven, E., & Gündoğan, M. (2021). Investigation of the Effects of Lavender Oil Aromatherapy to Prevent Preoperative Anxiety in Patients Scheduled for Tympanoplasty. International J

Questions about this trial

What is this clinical trial studying?

A study testing Lavender essential oil inhalation, Music intervention and routine care in people with Cardiology and Angiography, run by Istanbul Aydın University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 12 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Patient Information Form (time frame: First day). The study lists 11 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07514299, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in